OTCMKTS:SFOSF Shanghai Fosun Pharmaceutical (Group) (SFOSF) Stock Price, News & Analysis $1.97 0.00 (0.00%) As of 05/30/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About Shanghai Fosun Pharmaceutical (Group) Stock (OTCMKTS:SFOSF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SFOSF alerts:Sign Up Key Stats Today's Range$1.97▼$1.9750-Day Range$1.90▼$1.9752-Week Range$1.50▼$2.24VolumeN/AAverage Volume5,080 shsMarket CapitalizationN/AP/E Ratio1.68Dividend Yield13.71%Price TargetN/AConsensus RatingN/A Company OverviewShanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, anti-infection, API's and intermediate, metabolism, alimentary system, cardiovascular and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services, and investment management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.Read More… Shanghai Fosun Pharmaceutical (Group) Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreSFOSF MarketRank™: Shanghai Fosun Pharmaceutical (Group) scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Shanghai Fosun Pharmaceutical (Group). Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Shanghai Fosun Pharmaceutical (Group) is 1.68, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.23.Price to Earnings Ratio vs. SectorThe P/E ratio of Shanghai Fosun Pharmaceutical (Group) is 1.68, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.85. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverShanghai Fosun Pharmaceutical (Group) has a short interest ratio ("days to cover") of 100.8, which indicates bearish sentiment.Change versus previous month Dividend1.7 / 5Dividend StrengthWeak Dividend YieldShanghai Fosun Pharmaceutical (Group) pays a meaningful dividend of 1.21%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthShanghai Fosun Pharmaceutical (Group) does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Shanghai Fosun Pharmaceutical (Group) is 23.08%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Shanghai Fosun Pharmaceutical (Group)'s dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverShanghai Fosun Pharmaceutical (Group) has a short interest ratio ("days to cover") of 100.8, which indicates bearish sentiment.Change versus previous month News and Social Media3.1 / 5News SentimentN/A News SentimentShanghai Fosun Pharmaceutical (Group) has a news sentiment score of 1.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Shanghai Fosun Pharmaceutical (Group) this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Shanghai Fosun Pharmaceutical (Group) insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 4.64% of the stock of Shanghai Fosun Pharmaceutical (Group) is held by institutions.Read more about Shanghai Fosun Pharmaceutical (Group)'s insider trading history. Receive SFOSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shanghai Fosun Pharmaceutical (Group) and its competitors with MarketBeat's FREE daily newsletter. Email Address SFOSF Stock News HeadlinesFosun Pharma’s Subsidiary Gains Approval for New Drug LuvometinibMay 29 at 7:21 AM | tipranks.comSee More Headlines SFOSF Stock Analysis - Frequently Asked Questions How have SFOSF shares performed this year? Shanghai Fosun Pharmaceutical (Group)'s stock was trading at $1.8003 at the beginning of 2025. Since then, SFOSF stock has increased by 9.4% and is now trading at $1.97. View the best growth stocks for 2025 here. How do I buy shares of Shanghai Fosun Pharmaceutical (Group)? Shares of SFOSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:SFOSF CIKN/A Webwww.fosunpharma.com Phone86-21-3398-7000FaxN/AEmployees40,370Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio1.68 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (OTCMKTS:SFOSF) was last updated on 5/31/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shanghai Fosun Pharmaceutical (Group) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.